GYN&FORM
ActiveSummary
GYN&FORM has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €193k and a net result of €99k. Equity is growing by ~58.9% per year across the filed fiscal years. Its solvency ranks better than 61% of 2344 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability95=
Solvency97▲+13
Growth78▲+26
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18k at 30 days acceptable
Liquidity ample (current ratio 6.2 against 5.3 in 2024; short-term debt: 15.7% and cash: 75.4% of total assets), and 28.2% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
71.8%
Return on assets
37%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filingsDeviation from the deadline
2025
24 d late
2024
3 d early
2023
31 d late
2022
20 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€99k▲ 193%
2024 · €34k
Working capital
€220k▲ 81.7%
2024 · €121k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line2022202320242025
Operating result€51k-€26k▼ 48.9%€55k▲ 111%€159k▲ 188%
Net result€41k-€18k▼ 56.6%€34k▲ 88.8%€99k▲ 193%
Equity€44k-€61k▲ 39.1%€94k▲ 54.2%€193k▲ 105%
Total assets€106k-€89k▼ 16.0%€161k▲ 80.7%€269k▲ 67.1%
Debt€62k-€28k▼ 55.0%€36k▲ 29.7%€44k▲ 22.9%
Working capital€40k-€57k▲ 42.4%€121k▲ 111%€220k▲ 81.7%
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 188% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €269k
Fixed assets
€6k ▼ 46.2%
Current assets
€262k ▲ 75.8%
Equity and liabilities €269k
Equity
€193k ▲ 105%
Provisions
€31k ▲ 3.2%
Debt
€44k ▲ 22.9%
Debt's share of the balance-sheet total falls from 22.5% to 16.6%. Equity and debt are higher.
Key figures and ratios
EBITDA
€164k▲
2024 · €60k
Cash flow
€104k▲
2024 · €39k
Current ratio
6.20▲
2024 · 5.30
Debt to equity
0.23▼
2024 · 0.38
ROE
51.6%▲
2024 · 36.1%
ROA
37.0%▲
2024 · 21.1%
Interest coverage
5.42▼
2024 · 37.57
Debt ≤ 1 year
€42k▲
2024 · €28k
Debt > 1 year
€2k▼
2024 · €7k
Income taxes
€29k▲
2024 · €20k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €4k | €5k | €5k | €5k | = |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | - | - | €30k | €986 | ▼ 96.8% |
| Other operating charges640/8 | €50 | - | €387 | €400 | ▲ 3.2% |
| Gross operating margin9900 | €55k | €31k | €91k | €165k | ▲ 81.7% |
| Operating profit (loss)9901 | €51k | €26k | €55k | €159k | ▲ 188% |
| Financial income75/76B | €0 | €0 | €43 | - | - |
| Recurring financial income75 | €0 | €0 | €43 | - | - |
| Financial charges65/66B | €590 | €605 | €2k | €30k | ▲ 1,788% |
| Recurring financial charges65 | €590 | €605 | €2k | €30k | ▲ 1,788% |
| Profit (loss) for the period before taxes9903 | €51k | €26k | €54k | €129k | ▲ 140% |
| Income taxes67/77 | €9k | €8k | €20k | €29k | ▲ 48.7% |
| Profit (loss) for the period9904 | €41k | €18k | €34k | €99k | ▲ 193% |
| Profit (loss) for the period to be appropriated9905 | €41k | €18k | €34k | €99k | ▲ 193% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €106k | €89k | €161k | €269k | ▲ 67.1% |
| Fixed assets21/28 | €21k | €16k | €12k | €6k | ▼ 46.2% |
| Tangible fixed assets22/27 | €21k | €16k | €11k | €6k | ▼ 44.0% |
| Plant, machinery and equipment23 | €21k | €16k | €11k | €6k | ▼ 44.0% |
| Financial fixed assets28 | €455 | €455 | €455 | - | - |
| Current assets29/58 | €85k | €73k | €149k | €262k | ▲ 75.8% |
| Amounts receivable within one year40/41 | €476 | €275 | €12k | €1k | ▼ 88.7% |
| Trade receivables40 | €476 | - | €1k | €1k | = |
| Other amounts receivable41 | - | €275 | €10k | - | - |
| Current investments50/53 | - | €1k | €12k | €15k | ▲ 25.5% |
| Cash at bank and in hand54/58 | €26k | €44k | €86k | €202k | ▲ 135% |
| Deferred charges and accrued income490/1 | €58k | €27k | €39k | €43k | ▲ 10.6% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €106k | €89k | €161k | €269k | ▲ 67.1% |
| Equity10/15 | €44k | €61k | €94k | €193k | ▲ 105% |
| Contributions10/11 | €3k | €3k | €3k | €3k | = |
| Reserves13 | - | €59k | €92k | €190k | ▲ 108% |
| Distributable reserves133 | - | €59k | €92k | €190k | ▲ 108% |
| Profit (loss) carried forward14 | €41k | - | - | - | - |
| Provisions and deferred taxes16 | - | - | €30k | €31k | ▲ 3.2% |
| Provisions for liabilities and charges160/5 | - | - | €30k | €31k | ▲ 3.2% |
| Other liabilities and charges164/5 | - | - | €30k | €31k | ▲ 3.2% |
| Amounts payable17/49 | €62k | €28k | €36k | €44k | ▲ 22.9% |
| Amounts payable after more than one year17 | €17k | €12k | €7k | €2k | ▼ 70.2% |
| Financial debts170/4 | €17k | €12k | €7k | €2k | ▼ 70.2% |
| Amounts payable within one year42/48 | €44k | €15k | €28k | €42k | ▲ 50.3% |
| Current portion of amounts payable after more than one year42 | €5k | €5k | €5k | €5k | ▲ 2.8% |
| Trade debts44 | €59 | - | €1k | €514 | ▼ 59.3% |
| Suppliers440/4 | €59 | - | €1k | €514 | ▼ 59.3% |
| Taxes, remuneration and social security45 | €11k | €10k | €14k | €15k | ▲ 4.4% |
| Taxes450/3 | €11k | €10k | €14k | €15k | ▲ 4.4% |
| Other amounts payable47/48 | €28k | €800 | €8k | €22k | ▲ 185% |
| Accrued charges and deferred income492/3 | €680 | €550 | €800 | - | - |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €41k | €18k | €34k | €99k | ▲ 193% |
| + Depreciation and write-downs630 | €4k | €5k | €5k | €5k | = |
| Operating cash flow (approximation) | €45k | €23k | €39k | €104k | ▲ 169% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €455 | - |
| Change in cash | - | €18k | €42k | €116k | ▲ 176% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 24 days late
2025
31-12
Financial
Highest result since 2022net €99k ▲193%
Operating result €159k, net result €99k, both a record.
31-12
Financial
Equity above €150kEq €193k ▲105%
4 profitable years in a row build equity to €193k.
28-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 31 days late
2023
31-12
Financial
Weakest financial yearnet €18k ▼56.6%
Net result drops to €18k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity triplescurrent ratio 4.79
Current ratio from 1.91 to 4.79; short-term debt falls from €44k to €15k.
11-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Esneux · 1 establishment unit since 2022
Ground area
504 m²
Building footprint
79 m²
Volume, LiDAR
513 m³
Parcel 62101A0497/00A003, Wallonia · tallest building 9.2 m, ±2 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
Rue de Limoges 112, 4130 Esneux
since 20222.327.249.140
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62101A0497/00A003 | Wallonia | 504 m² | 1 · 79 m² | 9.2 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
9845006A575CD57AF408
Similar companies · same sector, comparable size
Société médicale Vinciane Laret
BE 0823.387.270
Liège · Eq €192,616
DR. TOM BLOOTACKER
BE 0890.043.888
Jodoigne · Eq €192,840
MACUSAN
BE 1016.106.771
Elsene · Eq €192,584
SCANRE
BE 1012.441.062
Turnhout · Eq €192,873
Vercomed
BE 0759.934.721
Alken · Eq €192,906
Of 16,630 companies in sector 86220 we hold annual accounts for 7,979. 6,739 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded13-01-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Scores and ratios are computed by Checked and are not a credit decision.